VRDN

NASDAQStock

Viridian Therapeutics, Inc.

$28.61-0.05 (-0.17%)

52-Week Range

$11.02

$33.78

Key Stats

Market Cap

2.4B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Volume

760.1K

Avg Volume

1.2M

Performance

-5.49%

-12.07%

+57.75%

YTD

-7.40%

+70.63%

-1.53%

+52.33%

Price Chart

ETF Exposure

VRDN is held by 81 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
HDG	ProShares - Hedge Replication ETF	0.01%	89	$3K	$23.2M	0.95%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	29,711	$867K	$9.01B	0.21%
DCOR	Dimensional - US Core Equity 1 ETF	0.01%	5,248	$153K	$2.68B	0.14%
DFAC	Dimensional - US Core Equity 2 ETF	0.01%	87,462	$2.6M	$41.36B	0.17%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	14,629	$427K	$10.55B	0.12%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	106,627	$3.1M	$81.53B	0.03%
SCHB	Schwab U.S. Broad Market ETF	0.00%	48,010	$1.4M	$38.14B	0.03%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	2,246	$63K	$1.43B	0.09%
VTHR	Vanguard Russell 3000 ETF	0.00%	6,958	$230K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,804,070	$92.5M	$2.10T	0.03%
IWV	iShares Russell 3000 ETF	0.00%	19,165	$559K	$17.58B	0.20%
DFUS	Dimensional - US Equity Market ETF	0.00%	11,057	$323K	$18.80B	0.09%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	31	$904	$33.4M	0.34%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	3	$92	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	4	$113	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	21	$618	$30.3M	0.32%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	38	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	44	$1K	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	52	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	43	$1K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	28	$828	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	21	$626	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	10	$278	$9.5M	0.12%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	4	$116	$26.4M	0.50%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	7	$196	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	22	$649	$81.5M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,327	$44K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,327	$44K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,327	$44K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,327	$44K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,327	$44K	$3.7M	0.70%

PreviousPage 2 of 2

About VRDN ETF Exposure

Viridian Therapeutics, Inc. (VRDN) is held by 81 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, VRDN is a widely held institutional stock. The stock currently trades at $28.61. Investors can gain exposure to VRDN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRDN, sorted by portfolio weight.